Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
SSerina Therapeutics Inc. logo
SERNYSE

Serina Therapeutics Inc.

Serina Therapeutics Inc.
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

May 14
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Mar 25
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2025
Nov 13
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Aug 11
Earnings Time TBD
Q2 earnings
Add to Google Calendar
May 8
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Mar 24
Earnings Time TBD
Full-year earnings
Add to Google Calendar
Jan 6
Earnings Time TBD
Full-year earnings
Add to Google Calendar
2024
Nov 12
Earnings Time TBD
Q3 earnings
Add to Google Calendar
Aug 9
Earnings Time TBD
Q2 earnings
Add to Google Calendar
May 14
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Nov 12
Est.
Earnings 16:05 approx.
Q3 earnings (predicted)
Add to Google Calendar
2027
Jan 7
Est.
Earnings 16:05 approx.
FY earnings (predicted)
Add to Google Calendar
Jun 24
Est.
Shareholder meeting Time TBD
Annual meeting (est.)
Add to Google Calendar

KPI highlights

FY25
Revenue $130,000 YoY +132.1%
Operating income $-24M margin -18478.5%
Net income $-19M YoY —
EPS $-1.91 YoY —
P/E —
ROE 51843.2% Sign disagrees with net income (may reflect a one-time accounting item)

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue -0.010.000.000.000.000.00
Operating income -5.55-5.86-5.57-6.39-6.21-6.28
Net income -2.75-4.82-6.46-4.60-3.34-6.90
Operating CF -2.63-3.40-4.57-2.67-3.03-3.10

F-Score (Piotroski)

2/7 1 of 7 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

ROE and related signals above include a period where the sign disagrees with net income due to a one-time accounting item (see the ROE note in the KPI highlights above).

— Positive ROAExcluded from this period due to the net income/ROE sign mismatch N/A
✗ Positive operating cash flow $-18M
— ROA improved YoYExcluded from this period due to the net income/ROE sign mismatch N/A
✓ Operating CF exceeds net income (accrual quality) OCF $-18M / net income $-19M
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 9.5% → -0.5%
✗ Current ratio improved 2.40× → 1.71×
✗ No dilution (shares outstanding did not increase) 9,422,000 → 10,767,000
— Gross margin improved No data
✓ Asset turnover improved 0.01× → 0.02×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio -0.5%
Current ratio 1.7×
Years of positive operating CF 0 of last 9 yrs
Payout ratio 0%
Latest fiscal year result Loss (net loss $19M)

Performance history

Last 10 years
$0M$1M$2M$2M$3M FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 1.401.401.730.360.140.033.150.060.13
Operating income -6.66-11.2-12.6-10.1-7.93-6.98-3.13-17.0-24.0
Ordinary income —————————
Net income -6.58-7.50-12.2-10.9-8.68-10.55.27-11.1-19.2
Total assets 9.6310.77.443.933.153.248.976.726.95
Equity 7.287.452.22-5.12-11.8-17.2-32.30.64-0.04

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: $1M
Item FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS ————$-0.23$-0.28—$-1.51$-1.91
ROE -90.4%-100.7%-548.0%212.4%73.3%60.8%-16.3%-1738.1%51843.2%
Operating CF -6.29-8.00-10.2-7.82-7.86-5.94-2.48-17.1-18.0
Investing CF 0.011.33-0.36-0.020.670.98-0.50-0.02-0.06
Financing CF 13.36.006.275.967.256.0010.113.217.4
FCF ————-2.36-2.09—-17.2-18.0

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-03) *Some metrics supplemented from additional sources

Key financial metrics

High ROE ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data